{"result": {"id": "06d48184-88b0-45da-b99d-5bb8a6672f4e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "I notice the previous extraction missed several important entities and relationships from the medical text. Here are the additional ones that match the specified entity types (organization, person, geo, event):\n\n(\"entity\"<|>达喜<|>organization<|>达喜是铝碳酸镁片的品牌名，用于治疗胃酸相关疾病\")\n##\n(\"entity\"<|>舒利迭<|>organization<|>舒利迭是沙美特罗替卡松吸入剂的品牌名，用于哮喘和慢性阻塞性肺病治疗\")\n##\n(\"entity\"<|>环丙沙星<|>organization<|>环丙沙星是氟喹诺酮类抗生素的一种\")\n##\n(\"entity\"<|>莫西沙星<|>organization<|>莫西沙星是氟喹诺酮类抗生素的一种\")\n##\n(\"entity\"<|>左氧氟沙星<|>organization<|>左氧氟沙星是氟喹诺酮类抗生素的一种\")\n##\n(\"entity\"<|>氯丙嗪<|>organization<|>氯丙嗪是吩噻嗪类抗精神病药物的一种\")\n##\n(\"entity\"<|>奋乃近<|>organization<|>奋乃近是吩噻嗪类抗精神病药物的一种\")\n##\n(\"relationship\"<|>铝碳酸镁片<|>达喜<|>达喜是铝碳酸镁片的品牌名<|>10)\n##\n(\"relationship\"<|>沙美特罗替卡松吸入剂<|>舒利迭<|>舒利迭是沙美特罗替卡松吸入剂的品牌名<|>10)\n##\n(\"relationship\"<|>氟喹诺酮类<|>环丙沙星<|>环丙沙星属于氟喹诺酮类抗生素<|>10)\n##\n(\"relationship\"<|>氟喹诺酮类<|>莫西沙星<|>莫西沙星属于氟喹诺酮类抗生素<|>10)\n##\n(\"relationship\"<|>氟喹诺酮类<|>左氧氟沙星<|>左氧氟沙星属于氟喹诺酮类抗生素<|>10)\n##\n(\"relationship\"<|>吩噻嗪类<|>氯丙嗪<|>氯丙嗪属于吩噻嗪类抗精神病药物<|>10)\n##\n(\"relationship\"<|>吩噻嗪类<|>奋乃近<|>奋乃近属于吩噻嗪类抗精神病药物<|>10)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1753517838, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 554, "prompt_tokens": 5491, "total_tokens": 6045, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3520}, "prompt_cache_hit_tokens": 3520, "prompt_cache_miss_tokens": 1971}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ﻿药嘱（用药温馨提示）------第一期\n1、布洛芬的药嘱：\n1.1服用布洛芬时不能同时服用地高辛、甲氨蝶呤、以及口服降血糖药物等。\n   因为布洛芬和这些药物同时服用，会使血药浓度增高，甚至中毒！应当间隔时间服用。\n1.2服用布洛芬和呋塞咪以及高血压药物同时服用，会降低降压效果！应当间隔时间服用。\n1.3老年人、支气管哮喘、有消化性溃疡史、胃肠道出血人群慎用。\n1.4使用布洛芬，用于止痛不得超过5天，用于退烧不得超过3天。\n2、铝碳酸镁片（如达喜）：\n2.1与阿奇霉素、氟喹诺酮类（如环丙沙星、莫西沙星、左氧氟沙星等）；异烟肼、地高辛、头孢泊肟酯、四环素类（四环素、多西环素、米诺环素等）、吩噻嗪类（氯丙嗪、奋乃近等）、法莫替丁、雷尼替丁、西咪替丁等合用，会使这些药疗效减少。如需合用，服用时间应间隔1--2小时。\n3、硫酸氢氯吡格雷：\n3.1不能和奥美拉唑或艾司奥美拉唑合用。会使硫酸氢氯吡格雷疗效减少。\n4、沙美特罗替卡松吸入剂（舒利迭）等：\n4.1加了激素类的吸入剂，患者吸入后，应当及时用清水漱口，避免造成咽喉刺激或鹅口疮。\n5、多潘立酮、西沙比利等：\n5.1心脏病患者不能使用，可以换成莫沙必利。\n6、关于镇咳药：\n6.1最好的镇咳药是苯丙哌林，其次是右美沙芬，再其次是福尔可定。\n6.2以上镇咳药均会造成痰液黏稠，黏痰不容易咳出，所以需要联合祛痰药，但不同时使用。\n7、感冒药：\n7.1含对乙酰氨基酚的感冒药，服药期间不能喝酒，否则会引起急性肝损伤。\n7.2含伪麻黄碱的感冒药，高血压患者慎用。因为伪麻黄碱会使血管收缩，升高血压。\n8、解热镇痛药：\n8.1阿司匹林不能与布洛芬合用，否则会引起胃溃疡、胃出血的风险。\n8.2阿司匹林不能与华法林合用，否则会增加出血倾向（如鼻出血、牙龈出血、皮肤瘀斑等）。\n8.3对乙酰氨基酚不能与苯妥英钠、利福平合用，否则会降低疗效，产生肝损伤。\n9、胃肠道药物：\n9.1抗酸药（氢氧化铝、氢氧化镁等）：不与四环素类、奎若酮抗生素合用，否则会降低疗效。\n9.2抗酸药（氢氧化铝、氢氧化镁等）：不与维生素C合用，长期使用会导致维生素C缺乏。\n10、降压药：\n10\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>布洛芬<|>organization<|>布洛芬是一种解热镇痛药，不能与地高辛、甲氨蝶呤、口服降血糖药物等同时服用，否则会导致血药浓度增高甚至中毒。与呋塞咪和高血压药物同时服用会降低降压效果。老年人、支气管哮喘、有消化性溃疡史、胃肠道出血人群慎用。用于止痛不得超过5天，用于退烧不得超过3天。\")\n##\n(\"entity\"<|>地高辛<|>organization<|>地高辛是一种药物，与布洛芬同时服用会导致血药浓度增高甚至中毒。\")\n##\n(\"entity\"<|>甲氨蝶呤<|>organization<|>甲氨蝶呤是一种药物，与布洛芬同时服用会导致血药浓度增高甚至中毒。\")\n##\n(\"entity\"<|>口服降血糖药物<|>organization<|>口服降血糖药物是一类药物，与布洛芬同时服用会导致血药浓度增高甚至中毒。\")\n##\n(\"entity\"<|>呋塞咪<|>organization<|>呋塞咪是一种药物，与布洛芬同时服用会降低降压效果。\")\n##\n(\"entity\"<|>高血压药物<|>organization<|>高血压药物是一类药物，与布洛芬同时服用会降低降压效果。\")\n##\n(\"entity\"<|>铝碳酸镁片<|>organization<|>铝碳酸镁片（如达喜）是一种药物，与阿奇霉素、氟喹诺酮类、异烟肼、地高辛、头孢泊肟酯、四环素类、吩噻嗪类、法莫替丁、雷尼替丁、西咪替丁等合用会减少这些药物的疗效。如需合用，应间隔1-2小时服用。\")\n##\n(\"entity\"<|>阿奇霉素<|>organization<|>阿奇霉素是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>氟喹诺酮类<|>organization<|>氟喹诺酮类（如环丙沙星、莫西沙星、左氧氟沙星等）是一类药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>异烟肼<|>organization<|>异烟肼是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>头孢泊肟酯<|>organization<|>头孢泊肟酯是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>四环素类<|>organization<|>四环素类（四环素、多西环素、米诺环素等）是一类药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>吩噻嗪类<|>organization<|>吩噻嗪类（氯丙嗪、奋乃近等）是一类药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>法莫替丁<|>organization<|>法莫替丁是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>雷尼替丁<|>organization<|>雷尼替丁是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>西咪替丁<|>organization<|>西咪替丁是一种药物，与铝碳酸镁片合用会减少疗效。\")\n##\n(\"entity\"<|>硫酸氢氯吡格雷<|>organization<|>硫酸氢氯吡格雷是一种药物，不能与奥美拉唑或艾司奥美拉唑合用，否则会减少疗效。\")\n##\n(\"entity\"<|>奥美拉唑<|>organization<|>奥美拉唑是一种药物，与硫酸氢氯吡格雷合用会减少硫酸氢氯吡格雷的疗效。\")\n##\n(\"entity\"<|>艾司奥美拉唑<|>organization<|>艾司奥美拉唑是一种药物，与硫酸氢氯吡格雷合用会减少硫酸氢氯吡格雷的疗效。\")\n##\n(\"entity\"<|>沙美特罗替卡松吸入剂<|>organization<|>沙美特罗替卡松吸入剂（舒利迭等）是一种加了激素类的吸入剂，患者吸入后应及时用清水漱口，避免造成咽喉刺激或鹅口疮。\")\n##\n(\"entity\"<|>多潘立酮<|>organization<|>多潘立酮是一种药物，心脏病患者不能使用，可以换成莫沙必利。\")\n##\n(\"entity\"<|>西沙比利<|>organization<|>西沙比利是一种药物，心脏病患者不能使用，可以换成莫沙必利。\")\n##\n(\"entity\"<|>莫沙必利<|>organization<|>莫沙必利是一种药物，可以替代多潘立酮和西沙比利用于心脏病患者。\")\n##\n(\"entity\"<|>苯丙哌林<|>organization<|>苯丙哌林是一种镇咳药，被认为是效果最好的镇咳药。\")\n##\n(\"entity\"<|>右美沙芬<|>organization<|>右美沙芬是一种镇咳药，效果次于苯丙哌林。\")\n##\n(\"entity\"<|>福尔可定<|>organization<|>福尔可定是一种镇咳药，效果次于右美沙芬。\")\n##\n(\"entity\"<|>祛痰药<|>organization<|>祛痰药是一类药物，与镇咳药联合使用但不同时使用，以避免痰液黏稠不易咳出。\")\n##\n(\"entity\"<|>对乙酰氨基酚<|>organization<|>对乙酰氨基酚是一种感冒药成分，服药期间不能喝酒，否则会引起急性肝损伤。不能与苯妥英钠、利福平合用，否则会降低疗效并产生肝损伤。\")\n##\n(\"entity\"<|>伪麻黄碱<|>organization<|>伪麻黄碱是一种感冒药成分，高血压患者慎用，因为会使血管收缩，升高血压。\")\n##\n(\"entity\"<|>阿司匹林<|>organization<|>阿司匹林是一种解热镇痛药，不能与布洛芬合用，否则会引起胃溃疡、胃出血的风险。不能与华法林合用，否则会增加出血倾向。\")\n##\n(\"entity\"<|>华法林<|>organization<|>华法林是一种药物，与阿司匹林合用会增加出血倾向（如鼻出血、牙龈出血、皮肤瘀斑等）。\")\n##\n(\"entity\"<|>苯妥英钠<|>organization<|>苯妥英钠是一种药物，与对乙酰氨基酚合用会降低疗效并产生肝损伤。\")\n##\n(\"entity\"<|>利福平<|>organization<|>利福平是一种药物，与对乙酰氨基酚合用会降低疗效并产生肝损伤。\")\n##\n(\"entity\"<|>抗酸药<|>organization<|>抗酸药（氢氧化铝、氢氧化镁等）是一类药物，不与四环素类、奎若酮抗生素合用，否则会降低疗效。不与维生素C合用，长期使用会导致维生素C缺乏。\")\n##\n(\"entity\"<|>氢氧化铝<|>organization<|>氢氧化铝是一种抗酸药，不与四环素类、奎若酮抗生素合用，否则会降低疗效。不与维生素C合用，长期使用会导致维生素C缺乏。\")\n##\n(\"entity\"<|>氢氧化镁<|>organization<|>氢氧化镁是一种抗酸药，不与四环素类、奎若酮抗生素合用，否则会降低疗效。不与维生素C合用，长期使用会导致维生素C缺乏。\")\n##\n(\"entity\"<|>四环素类<|>organization<|>四环素类是一类药物，与抗酸药合用会降低疗效。\")\n##\n(\"entity\"<|>奎若酮抗生素<|>organization<|>奎若酮抗生素是一类药物，与抗酸药合用会降低疗效。\")\n##\n(\"entity\"<|>维生素C<|>organization<|>维生素C是一种营养素，与抗酸药长期合用会导致维生素C缺乏。\")\n##\n(\"relationship\"<|>布洛芬<|>地高辛<|>布洛芬与地高辛同时服用会导致血药浓度增高甚至中毒<|>9)\n##\n(\"relationship\"<|>布洛芬<|>甲氨蝶呤<|>布洛芬与甲氨蝶呤同时服用会导致血药浓度增高甚至中毒<|>9)\n##\n(\"relationship\"<|>布洛芬<|>口服降血糖药物<|>布洛芬与口服降血糖药物同时服用会导致血药浓度增高甚至中毒<|>9)\n##\n(\"relationship\"<|>布洛芬<|>呋塞咪<|>布洛芬与呋塞咪同时服用会降低降压效果<|>8)\n##\n(\"relationship\"<|>布洛芬<|>高血压药物<|>布洛芬与高血压药物同时服用会降低降压效果<|>8)\n##\n(\"relationship\"<|>铝碳酸镁片<|>阿奇霉素<|>铝碳酸镁片与阿奇霉素合用会减少阿奇霉素的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>氟喹诺酮类<|>铝碳酸镁片与氟喹诺酮类合用会减少氟喹诺酮类的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>异烟肼<|>铝碳酸镁片与异烟肼合用会减少异烟肼的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>头孢泊肟酯<|>铝碳酸镁片与头孢泊肟酯合用会减少头孢泊肟酯的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>四环素类<|>铝碳酸镁片与四环素类合用会减少四环素类的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>吩噻嗪类<|>铝碳酸镁片与吩噻嗪类合用会减少吩噻嗪类的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>法莫替丁<|>铝碳酸镁片与法莫替丁合用会减少法莫替丁的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>雷尼替丁<|>铝碳酸镁片与雷尼替丁合用会减少雷尼替丁的疗效<|>7)\n##\n(\"relationship\"<|>铝碳酸镁片<|>西咪替丁<|>铝碳酸镁片与西咪替丁合用会减少西咪替丁的疗效<|>7)\n##\n(\"relationship\"<|>硫酸氢氯吡格雷<|>奥美拉唑<|>硫酸氢氯吡格雷与奥美拉唑合用会减少硫酸氢氯吡格雷的疗效<|>8)\n##\n(\"relationship\"<|>硫酸氢氯吡格雷<|>艾司奥美拉唑<|>硫酸氢氯吡格雷与艾司奥美拉唑合用会减少硫酸氢氯吡格雷的疗效<|>8)\n##\n(\"relationship\"<|>多潘立酮<|>莫沙必利<|>多潘立酮不能用于心脏病患者，可以换成莫沙必利<|>6)\n##\n(\"relationship\"<|>西沙比利<|>莫沙必利<|>西沙比利不能用于心脏病患者，可以换成莫沙必利<|>6)\n##\n(\"relationship\"<|>苯丙哌林<|>祛痰药<|>苯丙哌林等镇咳药需要联合祛痰药使用，但不同时使用<|>5)\n##\n(\"relationship\"<|>右美沙芬<|>祛痰药<|>右美沙芬等镇咳药需要联合祛痰药使用，但不同时使用<|>5)\n##\n(\"relationship\"<|>福尔可定<|>祛痰药<|>福尔可定等镇咳药需要联合祛痰药使用，但不同时使用<|>5)\n##\n(\"relationship\"<|>对乙酰氨基酚<|>苯妥英钠<|>对乙酰氨基酚与苯妥英钠合用会降低疗效并产生肝损伤<|>8)\n##\n(\"relationship\"<|>对乙酰氨基酚<|>利福平<|>对乙酰氨基酚与利福平合用会降低疗效并产生肝损伤<|>8)\n##\n(\"relationship\"<|>阿司匹林<|>布洛芬<|>阿司匹林与布洛芬合用会引起胃溃疡、胃出血的风险<|>9)\n##\n(\"relationship\"<|>阿司匹林<|>华法林<|>阿司匹林与华法林合用会增加出血倾向<|>8)\n##\n(\"relationship\"<|>抗酸药<|>四环素类<|>抗酸药与四环素类合用会降低四环素类的疗效<|>7)\n##\n(\"relationship\"<|>抗酸药<|>奎若酮抗生素<|>抗酸药与奎若酮抗生素合用会降低奎若酮抗生素的疗效<|>7)\n##\n(\"relationship\"<|>抗酸药<|>维生素C<|>抗酸药与维生素C长期合用会导致维生素C缺乏<|>6)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_0fc01ae52f22348b2c1e46c7b9c832d7dfc3abc6b473e344f0680f553a4c6183_v2"}